Yanli Ding

,

Credentials

MD, PhD

Research Summary

Dr. Ding's research interests are in the development of organoid-based models for the study of neuroendocrine tumors and targeted drug therapies for metastatic renal cell carcinomas.

• Renal histology and pathology
• Neuroendocrine cancer

Publications

Lee HJ, Donati A, Feliers D, Sun Y, Ding Y, Madesh M, Salmon AB, Ikeno Y, Ross C, O'Connor CL, Ju W. Chloride channel accessory 1 integrates chloride channel activity and mTORC1 in aging‐related kidney injury. Aging Cell. 2021 Jun 12:e13407.

Agarwal AN, Shieh WJ, Goldsmith CS, Qvarnstrom Y, Ding Y, Dallas SD, Mais DD. The brief case: Disseminated microsporidiosis with intestinal cryptosporidium coinfection in a patient with Kaposi’s Sarcoma and Castleman Disease presenting with acute kidney injury. Journal of Clinical Microbiology. 2021 May 19;59(6):e02335-20.

Armaiz-Pena, G., Flores, S. K., Cheng, Z.M. ... Ding, Y, Dahia, P. Genotype-phenotype features of germline variants of the TMEM127 pheochromocytoma susceptibility gene: A 10-Year Update. The Journal of Clinical Endocrinology & Metabolism. 2021 Jan;106(1):e350-64.

Kincaide E, Hitchman K, Hall R, Yamaguchi I, Ding Y, Crowther B. Impact of active antibody‐ mediated rejection treatment on donor‐specific antibodies in pediatric kidney transplant recipients. Pediatric Transplantation. 2019 Dec;23(8):e13590.